Kellerhals Carrard has announced the appointment of eight new partner and three new counsels. Meet the new partners Martin Föhse first joined Kellerhals Carrard in 2015. He specialises in constitutional and administrative law. He advises
Tags :Kellerhals Carrard
Vifor Pharma Group closed its divestment transaction regarding its finished drug product manufacturing business with facilities in Fribourg, Ettingen (both in Switzerland) and Lisbon (Portugal) to CordenPharma, a full-service Contract Development & Manufacturing Organisation (CDMO)
The shareholders of Webland, a Swiss provider of webhosting, domain registration and xDSL services, have sold their shares together with their shares in the German Webland Internet Service Gesellschaft to the Swedish Miss Group. Kellerhals
BKW acquires the UMB Group, an independent full-service IT provider in the Swiss market with around 500 employees at 11 locations and sales in the low three-digit million range. With this acquisition, BKW is taking a significant
Benevity, global specialists in ESG technology, acquired Alaya, a purpose-driven employee engagement SaaS platform based in Switzerland. The addition of Alaya will allow Benevity to expand its international presence and enable more companies to access
Gruner, an engineering and planning company, takes over Zeltner Ingenieure, Belp, adding it to its business unit “Infrastruktur Bern, Raumplanung”, effective January 1, 2022. Zeltner Ingenieure are active as spatial planners and civil engineers in the areas
The Hirslanden Group acquires a stake of about 10% in Spital Lachen, takes a seat on the Board of Directors and cooperates with Spital Lachen in various areas, enabling it to strengthen its portfolio and to
VetPartners expands its European portfolio with the acquisition of Swiss-based Swissvet Group. Founded 2016, Swissvet Group employs more than 120 people in 12 veterinary practices in French-speaking Switzerland. Florent Bourachot, one of the co-founders of Swissvet group and
RealUnit Schweiz, a Swiss investment company that invests broadly diversified in real assets and shares, has successfully listed more than 18 million bearer shares on the BX Swiss on November 29,2021. Kellerhals Carrard acts as legal counsel
Kellerhals Carrard represented Moderna biotechnology company as it was heard as a third party in the inspection of the Control Committee of the National Council (CC-N) that was launched in May 2020 regarding the handling of
